Media

Events
RepliCel Presents its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference
Kanagawa Regeneration and Cell Medical Industry Network Organizers Invite RepliCel to Participate in Foreign Company...
As Seen In
Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner
Canada-based biotech company signs major deal with Chinese partner to advance groundbreaking technology in the...
As Seen In
Partnership Greenlighted for Canadian Biotech and Chinese Health Products Firm
RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB) and YOFOTO Health Industry Co. Ltd. received approval from...
As Seen In
Canadian Technology and Innovation: making strides in the global cell therapy landscape
Another cell therapy rising star, RepliCel Life Sciences, is harnessing the healing properties of hair...
As Seen In
9 Challenges Keeping Cell And Gene Therapy Executives Up At Night
Despite recent progress in regenerative medicine, cell and gene therapy executives are still pioneering many...
As Seen In
Is the Age-Old Quest for a Baldness Cure Reaching Its End?
Click here to read the full article and interview as it appears in The New...
As Seen In
RepliCel's regenerative technology could take the "Polar Silk Road" to China
New opportunities are arising at every turn for the regenerative medicine community. READ ARTICLE ...
As Seen In
Regenerative Medicine Company's China Deal is 'Dramatically Transformational'
Echelon Wealth Partners detailed the terms and impact of this cell therapy developer's recent alliance...
As Seen In
From stem cells to revenue: Bringing regenerative medicine to the masses
RepliCel lands Asian partnership to optimize the development of its biotech solutions for chronic conditions....
As Seen In
RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
Click here to read the full article and interview as it appears in Life Science:...
As Seen In
Japan is Fertile Ground for Biotech Deal
Click here to read the full article as it appears in the Streetwise Reports: The...
As Seen In
Company Uses Patients' Own Cells to Put an End to Baldness, Aging Skin and Tendon Degeneration
Company Uses Patients' Own Cells To Put An End To Baldness, Aging Skin And Tendon...
As Seen In
Analyst Says Cell Therapy Company’s Move Decreases Risk
Click here to read the full article as it appears in the Streetwise Reports (08/23/17)....
As Seen In
Your Hair Follicles May Hold the Key to Younger Looking Skin
Click here to read the full article as it appears in the New York Daily...
As Seen In
Skin in the Game
To read the full article as it appears on DDN News (08/08/17), click here. ...
As Seen In
Why RepliCel May Be the Most Compelling Biotech Company to Watch in Canada
To read the brief and watch the interview provided by Market One Media Group as...
As Seen In
RepliCel Poised To Partner Up For Precision-Control Dermal Injector
To preview the interview with Tina Tan as it appears on Medtech.com, click here. (6/23/17)
As Seen In
Hair-Raising R&D: RepliCel Developing Autologous Cell Therapy for Baldness
To read the full article as it appears on BioPharma-reporter.com, click here. (7/12/17) ...
As Seen In
Poised for Success with Positive Clinical Results
To read the full interview as it appears on Costmeticosbr.com.br, click here (7/6/17).
As Seen In
A New Approach to Treating Hair Loss
To read the full interview as it appears on Technologyworks.com, click here. (6/27/17)
{
  "Pagination": {
  "CurrentPage": 1,
  "ItemsPerPage": 20,
  "NumberOfPages": 5,
  "TotalItemsCount": 91
},
  "Items": [
  {
    "Id": 2711,
    "Url": "/news/replicel-presents-its-technology-development-and-commercialization-plans-for-japan-at-kanagawa-regenerative-medicine-industry-conference",
    "ParentId": 1929,
    "LastUpdatedDate": "2021-02-17T19:24:07",
    "Name": "RepliCel Presents its Technology   Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference",
    "UrlSlug": "replicel-presents-its-technology-development-and-commercialization-plans-for-japan-at-kanagawa-regenerative-medicine-industry-conference",
    "Enabled": true,
    "ReleaseDate": "2021-02-18T06:15:00",
    "ExpiryDate": "2099-12-12T08:00:00",
    "Weighting": 0,
    "Description": "

Kanagawa Regeneration and Cell Medical Industry Network Organizers Invite RepliCel to Participate in Foreign Company Pitch Session

VANCOUVER, BC, CANADA – 18 February 2021 – RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, announced its President and CEO, R. Lee Buckler, will present today at the RINK Festival hosted by the Regenerative Medicine & Cell Therapy Industrialization Network of Kanagawa (RINK), Kanagawa Prefecture.

The annual event is held to strengthen connections and collaborations in the regenerative medicine industry in Japan. A link to RepliCel's presentation (English audio and Japanese text) will be posted shortly after the event. To learn more, visit https://rinkrink.jp/2021.  

RepliCel is participating at the express invitation of the Canadian office of the Japan External Trade Organization (JETRO) which is one of the event sponsors along with Japan's Forum for Innovative Regenerative Medicine (FIRM), Japan's Ministry of Economy, Trade and Industry (METI), the Japan Ministry of Economy, Trade and Industry Patent Office, the Kansai Regenerative Medicine Industry Consortium (KRIC), Kyoto Institute of Advanced Technology (ASTEM), Keio University, Life Science Innovation Network Japan (LINK-J), Japan Biotech Council, Kanagawa Prefectural Industrial Technology Research Institute (KISTEC), Shonan Health Innovation Park (iPark), Quebec Government Office in Japan, and Mizuho Information Research Institute Co., Ltd.

About RepliCel's Programs in Japan

RepliCel signed its first co-development and licensing agreement with a Japanese partner in 2013 for a product currently in ongoing clinical research in Japan.

RepliCel is currently laying plans for the clinical testing and commercialization of three additional technologies in Japan.  These include two cell therapies - one for skin rejuvenation and one for tendon regeneration - and a next-generation dermal injector for aesthetic treatments involving a wide variety of injectable substances including cells, PRP, toxins, fillers, enzymes, drugs, other biologics, etc.

The RepliCel cell therapy technology which is the subject of active, ongoing partnership discussions in Japan has already been the subject of two successfully completed consultations with Japan's Pharmaceutical and Medical Devices Agency (PMDA). Planning for clinical research studies under Japan's Act for the Safety of Regenerative Medicines (ASRM) is already underway with two well-respected clinical professors of orthopedic sports medicine and clinical dermatology. Manufacturing of the clinical product will be performed by a Japanese-owned contract manufacturer preparing now for PMDA-certification under Japan's Ministry of Health, Labour, and Welfare (MHLW) applicable guidelines. Conduct of the clinical research studies will be managed by a high-quality Japanese clinical research organization.

About RepliCel Life Sciences

RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately one in three people in industrialized nations, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration.  These conditions, often associated with aging, are caused by a deficit of healthy cells required for normal tissue healing and function.  

Headquartered in Canada with a base of operations in Europe, RepliCel has existing partnerships in the United States, Japan and China.

The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. All RepliCel’s cell therapy product candidates are based on RepliCel’s innovative technology, utilizing cell populations isolated from a patient’s healthy hair follicles.  RepliCel's three cell therapy products have now been tested in over 100 patients in four countries on three continents and successfully reviewed by three different regulatory agencies.  

RepliCel has also developed a proprietary injection device, RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications. Certain commercial rights for RCI-02 have been licensed to YOFOTO for Greater China and a limited-term exclusive distributorship to MainPointe for the United States.

The commercial rights for RCH-01 for most of Asia have been exclusively licensed to Shiseido Company. Though the legal status of this license is currently the subject of some disagreement between the parties, Shiseido continues to finance the development of the licensed product based on RepliCel’s technology in their territory.  The commercial rights for RCT-01 and RCS-01 have been exclusively licensed to YOFOTO (China) Health for Greater China. YOFOTO is also committed to financing the co-development of these products in their territory.  

For more information, please visit www.replicel.com or contact:

Lee Buckler, CEO and President

604-248-8693

info@replicel.com


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


", "ItemTags": [ "Media" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 0, "SocialMetaTags": "", "OpenGraphProperties": "", "SeoPriority": "0.5", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - Events" ], "ItemCategoryIdList": [ "5" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/RINKFESバナー用-1-1024x337.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1937, "Url": "/news/groundbreaking-biotech-company-takes-major-step-forward-with-deal-with-chinese-partner", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:03", "Name": "Groundbreaking Biotech Company Takes Major Step Forward with Deal with Chinese Partner", "UrlSlug": "groundbreaking-biotech-company-takes-major-step-forward-with-deal-with-chinese-partner", "Enabled": true, "ReleaseDate": "2018-10-16T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Canada-based biotech company signs major deal with Chinese partner to advance groundbreaking technology in the skin and tendon rejuvenation space.
READ FULL ARTICLE

", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030220, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/swr-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1942, "Url": "/news/partnership-greenlighted-for-canadian-biotech-and-chinese-health-products-firm", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:11", "Name": "Partnership Greenlighted for Canadian Biotech and Chinese Health Products Firm", "UrlSlug": "partnership-greenlighted-for-canadian-biotech-and-chinese-health-products-firm", "Enabled": true, "ReleaseDate": "2018-09-25T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB) and YOFOTO Health Industry Co. Ltd. received approval from their respective countries to complete the investment part of the partnership agreement between them, and that transaction is expected to occur soon.
READ FULL ARTICLE

", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030217, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/swr-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1943, "Url": "/news/canadian-technology-and-innovation-making-strides-in-the-global-cell-therapy-landscape", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:20:54", "Name": "Canadian Technology and Innovation: making strides in the global cell therapy landscape", "UrlSlug": "canadian-technology-and-innovation-making-strides-in-the-global-cell-therapy-landscape", "Enabled": true, "ReleaseDate": "2018-08-15T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Another cell therapy rising star, RepliCel Life Sciences, is harnessing the healing properties of hair follicles to address unmet medical needs in acute, chronic and genetic conditions. RepliCel’s product pipeline features a diverse portfolio spanning tendinopathies, pattern baldness, skin damage, and dermal injector medical devices.
READ FULL ARTICLE

", "ItemTags": [ "Media", "Tendon", "Hair", "Skin" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030219, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2018/Screen%20Shot%202018-11-09%20at%208.48.23%20AM.png", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1944, "Url": "/news/9-challenges-keeping-cell-and-gene-therapy-executives-up-at-night", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:20:46", "Name": "9 Challenges Keeping Cell And Gene Therapy Executives Up At Night", "UrlSlug": "9-challenges-keeping-cell-and-gene-therapy-executives-up-at-night", "Enabled": true, "ReleaseDate": "2018-07-24T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Despite recent progress in regenerative medicine, cell and gene therapy executives are still pioneering many new pathways as they shape science into never-before-realized medicinal applications.
READ FULL ARTICLE

", "ItemTags": [ "Media" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030218, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2018/Screen%20Shot%202018-11-09%20at%209.05.41%20AM.png", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1946, "Url": "/news/is-the-age-old-quest-for-a-baldness-cure-reaching-its-end-", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:07", "Name": "Is the Age-Old Quest for a Baldness Cure Reaching Its End?", "UrlSlug": "is-the-age-old-quest-for-a-baldness-cure-reaching-its-end-", "Enabled": true, "ReleaseDate": "2018-06-06T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Click here to read the full article and interview as it appears in The New Yorker (06/07/18).

", "ItemTags": [ "Media", "Hair" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1023745, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2018/new-yorker-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1947, "Url": "/news/replicel-s-regenerative-technology-could-take-the-polar-silk-road-to-china", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:22:13", "Name": "RepliCel's regenerative technology could take the \"Polar Silk Road\" to China", "UrlSlug": "replicel-s-regenerative-technology-could-take-the-polar-silk-road-to-china", "Enabled": true, "ReleaseDate": "2018-05-07T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

New opportunities are arising at every turn for the regenerative medicine community.
READ ARTICLE


", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030215, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2018/Screen%20Shot%202018-11-09%20at%208.48.23%20AM.png", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1949, "Url": "/news/regenerative-medicine-company-s-china-deal-is-dramatically-transformational-", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:14", "Name": "Regenerative Medicine Company's China Deal is 'Dramatically Transformational'", "UrlSlug": "regenerative-medicine-company-s-china-deal-is-dramatically-transformational-", "Enabled": true, "ReleaseDate": "2018-01-31T16:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Echelon Wealth Partners detailed the terms and impact of this cell therapy developer's recent alliance in Asia.

READ ARTICLE


", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030223, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/swr-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1952, "Url": "/news/from-stem-cells-to-revenue-bringing-regenerative-medicine-to-the-masses", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:01", "Name": "From stem cells to revenue: Bringing regenerative medicine to the masses", "UrlSlug": "from-stem-cells-to-revenue-bringing-regenerative-medicine-to-the-masses", "Enabled": true, "ReleaseDate": "2018-01-15T16:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

RepliCel lands Asian partnership to optimize the development of its biotech solutions for chronic conditions.

READ ARTICLE

", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 1030221, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/fp-logo2.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1954, "Url": "/news/replicel-ceo-anticipating-the-approval-of-their-dermal-injector-its-impact-in-europe-and-beyond", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:26", "Name": "RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond", "UrlSlug": "replicel-ceo-anticipating-the-approval-of-their-dermal-injector-its-impact-in-europe-and-beyond", "Enabled": true, "ReleaseDate": "2017-11-21T16:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Click here to read the full article and interview as it appears in Life Science: Investing News Network (11/22/17).

", "ItemTags": [ "Media" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 999961, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/INN-logo-rsz.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1955, "Url": "/news/japan-is-fertile-ground-for-biotech-deal", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:08", "Name": "Japan is Fertile Ground for Biotech Deal", "UrlSlug": "japan-is-fertile-ground-for-biotech-deal", "Enabled": true, "ReleaseDate": "2017-10-25T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Click here to read the full article as it appears in the Streetwise Reports: The Life Sciences Report (10/26/17)

", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 996212, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/swr-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1957, "Url": "/news/company-uses-patients-own-cells-to-put-an-end-to-baldness-aging-skin-and-tendon-degeneration", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:20:58", "Name": "Company Uses Patients' Own Cells to Put an End to Baldness, Aging Skin and Tendon Degeneration", "UrlSlug": "company-uses-patients-own-cells-to-put-an-end-to-baldness-aging-skin-and-tendon-degeneration", "Enabled": true, "ReleaseDate": "2017-09-28T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Company Uses Patients' Own Cells To Put An End To Baldness, Aging Skin And Tendon Degeneration

By Robin Seaton Jefferson

Forbes Magazine. September 29, 2017.

Hollywood has made movies about it. Industries have made billions from it. And if the volume of scripture is any indication, the Almighty God must have placed great value on his creation of the head of human hair. After all, He gave Samson—the strongest man of whom the Bible tells—his immense strength through his hair and declared a woman’s hair \"a glory unto\" her in the 11th chapter of 1 Chorinthians.

Is it any wonder men and women obsess over their hair? And though we may get wiser as we age (a good thing), most of us don’t get hairier—at least not in the places we want to (not a good thing).

But there is a Canadian company who has been working diligently to change that.

To read the full article, please go to the Forbes Magazine article.

", "ItemTags": [ "Media", "Tendon", "Hair", "Skin" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 993247, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/Forbes-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1962, "Url": "/news/analyst-says-cell-therapy-company-s-move-decreases-risk", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:20:49", "Name": "Analyst Says Cell Therapy Company’s Move Decreases Risk", "UrlSlug": "analyst-says-cell-therapy-company-s-move-decreases-risk", "Enabled": true, "ReleaseDate": "2017-08-24T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Click here to read the full article as it appears in the Streetwise Reports (08/23/17).

", "ItemTags": [ "Media" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992274, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/swr-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1961, "Url": "/news/your-hair-follicles-may-hold-the-key-to-younger-looking-skin", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:22:24", "Name": "Your Hair Follicles May Hold the Key to Younger Looking Skin", "UrlSlug": "your-hair-follicles-may-hold-the-key-to-younger-looking-skin", "Enabled": true, "ReleaseDate": "2017-08-24T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

Click here to read the full article as it appears in the New York Daily News(08/24/17).

", "ItemTags": [ "Media", "Skin" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992275, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/ny-dailynews-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1965, "Url": "/news/skin-in-the-game", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:22:16", "Name": "Skin in the Game", "UrlSlug": "skin-in-the-game", "Enabled": true, "ReleaseDate": "2017-08-08T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To read the full article as it appears on DDN News (08/08/17), click here.

", "ItemTags": [ "Media", "Hair", "Skin" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992276, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/ddn-news-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1966, "Url": "/news/why-replicel-may-be-the-most-compelling-biotech-company-to-watch-in-canada", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:22:23", "Name": "Why RepliCel May Be the Most Compelling Biotech Company to Watch in Canada", "UrlSlug": "why-replicel-may-be-the-most-compelling-biotech-company-to-watch-in-canada", "Enabled": true, "ReleaseDate": "2017-07-30T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To read the brief and watch the interview provided by Market One Media Group as it appears on the FinancialPost.com, click here. (7/31/17)

", "ItemTags": [ "Media" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992277, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/fp-logo2.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1967, "Url": "/news/replicel-poised-to-partner-up-for-precision-control-dermal-injector", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:57", "Name": "RepliCel Poised To Partner Up For Precision-Control Dermal Injector", "UrlSlug": "replicel-poised-to-partner-up-for-precision-control-dermal-injector", "Enabled": true, "ReleaseDate": "2017-07-22T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To preview the interview with Tina Tan as it appears on Medtech.com, click here. (6/23/17)

", "ItemTags": [ "Media", "Partnerships" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992282, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/med-tech-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1968, "Url": "/news/hair-raising-r-d-replicel-developing-autologous-cell-therapy-for-baldness", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:03", "Name": "Hair-Raising R&D: RepliCel Developing Autologous Cell Therapy for Baldness", "UrlSlug": "hair-raising-r-d-replicel-developing-autologous-cell-therapy-for-baldness", "Enabled": true, "ReleaseDate": "2017-07-13T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To read the full article as it appears on BioPharma-reporter.com, click here. (7/12/17)

", "ItemTags": [ "Media", "Hair" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992278, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/bio-pharma-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1969, "Url": "/news/poised-for-success-with-positive-clinical-results", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:21:12", "Name": "Poised for Success with Positive Clinical Results", "UrlSlug": "poised-for-success-with-positive-clinical-results", "Enabled": true, "ReleaseDate": "2017-07-05T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To read the full interview as it appears on Costmeticosbr.com.br, click here (7/6/17).

", "ItemTags": [ "Media", "Tendon", "Hair", "Skin" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992279, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/RP-recent-coverage.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } }, { "Id": 1970, "Url": "/news/a-new-approach-to-treating-hair-loss", "ParentId": 1929, "LastUpdatedDate": "2019-08-01T06:20:47", "Name": "A New Approach to Treating Hair Loss", "UrlSlug": "a-new-approach-to-treating-hair-loss", "Enabled": true, "ReleaseDate": "2017-06-26T17:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "

To read the full interview as it appears on Technologyworks.com, click here. (6/27/17)

", "ItemTags": [ "Media", "Hair" ], "Author_Name": null, "Author_Url": null, "Author": "", "SEOTitle": "", "MetaTitle": "", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 992281, "SocialMetaTags": "", "OpenGraphProperties": { "title": null, "type": null, "url": null, "locale": null, "image": null }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": [ "News - As Seen In" ], "ItemCategoryIdList": [ "4" ], "SKUCode": "", "SiteSearchKeywords": "", "Image": "/Blog/2017/tech-networks-logo.jpg", "Module_ID": 1534, "Module_Alias": "BlogPost", "Pagination": { "CurrentPage": 1, "ItemsPerPage": 20, "NumberOfPages": 5, "TotalItemsCount": 91 }, "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Type": 3 } } ], "Params": { "type": "module", "source": "Blog Post", "layout": "List", "displayPagination": "true", "filterBy": "itemtags", "limit": "20", "filterValue": "Media", "sortBy": "releasedate", "sortOrder": "DESC", "collectionVariable": "posts" }, "Parent": { "Id": 1929, "Url": "/news", "ParentId": -1, "LastUpdatedDate": "2021-06-07T13:48:38", "Name": "News", "UrlSlug": "news", "Enabled": true, "ReleaseDate": "2018-11-27T16:00:00", "ExpiryDate": "2099-12-11T16:00:00", "Weighting": 0, "Description": "", "ItemTags": "", "Author_Name": "", "Author_Url": "", "Author": "", "SEOTitle": "Replicel News", "MetaTitle": "Replicel News", "MetaDescription": "", "ShowPageForSearchEngine": true, "CanonicalLink": "", "EnableAMP": false, "AMPContent": "", "CodeEditor": false, "ExternalId": 0, "SocialMetaTags": "", "OpenGraphProperties": { "title": "", "type": "", "url": "", "locale": "", "image": "" }, "SeoPriority": "", "DisableForSiteSearch": false, "CreatedByMemberId": 0, "ItemCategories": "", "ItemCategoryIdList": "", "SKUCode": "", "SiteSearchKeywords": "", "Module_ID": 1528, "Module_Alias": "Blog", "ParentName": "", "ParentUrl": "", "TemplateName": "News Template (Overall)", "IsHome": false } }

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.